Tag: biomedical
-
Safer Pain-Killing Drug Candidate Discovered
A research team from the U.S. and Germany identified a chemical molecule with pain-killing properties of opioids, but apparently without the dangerous side effects.
-
Phone-Linked Glucose Meter Shows Health, Monetary Benefits
The maker of a glucose meter that connects to cell-phone networks reports users of the device enjoy lower blood glucose readings and financial savings.
-
Leukemia Drug Shows Potential as Heart Attack Therapy
A new drug being tested as a leukemia treatment was shown in lab mice to reduce inflammatory white blood cells that lead to a build-up of arterial plaques and heart disease.
-
Robo-Bacteria Engineered for Cancer Drug Delivery
A biomedical engineering team designed a technology for precise deployment of drugs to tumors with bacteria modified to deliver their cargoes.
-
Gene Editing Negates Sickle Cell to Create Healthy Blood
Medical researchers developed a technique with genome editing to negate the effects of a mutation that causes inherited blood disorders like sickle cell disease.
-
Molecular Express, Baylor Medicine Partner on Vaccines
Vaccine developer Molecular Express and Baylor College of Medicine in Houston are developing boosters for vaccines from pieces of viruses that increase immune response to disease, including cancer.
-
NSF Funding Data Mining for Depression Diagnosis
A computer scientist at University of Texas in Arlington is developing data mining techniques and algorithms to help clinicians analyze unstructured notes accumulated from patients in therapy for depression.
-
Biopharm Company Raising $40 Million in IPO
Omeros Corporation, a biopharmaceutical company developing drugs that prevent inflammation in surgeries, is raising $40 million in its initial public stock offering.
-
New System Measures Oxygen Levels in ICU Patients
Researchers at University of Oxford in the U.K. designed a device that measures oxygen consumption in critically ill patients, to prevent occurrence of shock.
-
Patent Advances for Gut Damage Treatment Delivery
A developer of therapies for damage to an intestinal barrier received a notice that the U.S. intends to issue a patent protecting the technology to deliver the treatments.